Spring Bank Pharmaceuticals, Inc. (SBPH) Files Form 4 Insider Buying : Kurt M Eichler Buys 490 Shares

Spring Bank Pharmaceuticals, Inc. (SBPH): Kurt M Eichler , director of Spring Bank Pharmaceuticals, Inc. purchased 490 shares on Sep 13, 2016. The Insider buying transaction was reported by the company on Sep 14, 2016 to the Securities and Exchange Commission. The shares were purchased at $12.50 per share for a total value of $6,125.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 12, 2016, Nezam H. Afdhal (Chief Medical Officer) purchased 2,400 shares at $12.50 per share price.On Sep 2, 2016, Martin J Driscoll (CEO) purchased 1,000 shares at $11.75 per share price.Also, On Aug 24, 2016, Kurt M Eichler (director) purchased 3,000 shares at $10.73 per share price.On Aug 23, 2016, Jonathan Freve (CFO) purchased 1,000 shares at $10.74 per share price.

Leave a Reply

Spring Bank Pharmaceuticals, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Spring Bank Pharmaceuticals, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.